News & Information
At Memorial Sloan Kettering, our leading edge research is constantly advancing what we know about cancer and new discoveries are improving care for patients here, and all over the world. In News and Information, you will find information about our groundbreaking work and the dedicated professionals who make it all happen.
For Journalists
Connect with us to reach MSK experts for media inquiries and for story ideas.
MSK received top rankings in gynecology, urology, and several subspecialties
For more than 137 years, MSK has made historic contributions driving discovery and improving patient care. Take a look back at the progress we've made since the signing of the National Cancer Act in 1971.
In the News
Learn about some of the most important clinical advances made at MSK in 2021.
Take a look back at some of the biggest science stories from this past year.
Throughout the pandemic, Dr. Babady used her vast expertise in clinical microbiology and molecular diagnosis of infectious diseases to keep employees and patients safe.
Stay Connected with MSK
News Releases
Memorial Sloan Kettering Cancer Center (MSK) today announced that Rémy Evard has joined as its new Chief Digital Officer and Head of Technology.
Longtime donors Fiona and Stanley Druckenmiller have contributed a transformative gift of $100 million to MSK through their foundation. The gift will be used to launch the Fiona and Stanley Druckenmiller Presidential Innovation Fund.
Saad Usmani, MD, has been named Chief of the Myeloma Service at Memorial Sloan Kettering Cancer Center.
Media Coverage
Rémy Evard, previously a technology executive at a life-sciences venture-capital firm, has joined Memorial Sloan Kettering Cancer Center as chief digital officer and head of technology.
Friday, January 14, 2022
A new report says 3.5 million cancer deaths have been prevented in recent decades, thanks to declines in smoking, advances in treatments and improved early detection. MSK’s Deb Schrag is quoted.
Thursday, January 13, 2022
Memorial Sloan Kettering Cancer Center has created a fund to find more effective cancer treatments after receiving a $100 million gift from the Fiona and Stanley Druckenmiller Foundation. MSK’s Craig Thompson is quoted.
Wednesday, January 12, 2022
News from the Lab
Part natural killer, part T cell, this hybrid immune cell has a “double sword” for fighting cancer.
Could an implantable IUD help detect cancer early, when it is most curable? Scientists at the Sloan Kettering Institute are betting yes.
Meet Zhongmin Wang, a fifth-year doctoral student in the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK), who has been awarded the 2021 Chairman’s Prize.
MSK News
MSK is helping young patients navigate their journey and get the best treatment through specialized counseling, digital connections, and more. “The gratitude I feel is so deep. I’m not just alive; I’m living,” says Desiree Allen.
MSK doctors, such as Julia Glade Bender, are achieving better outcomes for patients by personalizing treatment on the basis of the biology of the cancer rather than the patient’s age.
Meet the Stuart family and learn why they want to revolutionize cancer treatment for people ages 15 to 39 and meet their very specific and often unmet needs.
2020 Annual Report: Meeting the Moment
MSK researchers like physician-scientist Karuna Ganesh are using an innovative technology called organoids to unlock the mysteries of cancer metastasis.
In her new role as Chief Health Equity Officer, gynecologic cancer surgeon Carol Brown is leading a new commitment to reducing cancer disparities. Dr. Brown spoke with NBC’s Today show anchor Al Roker about raising awareness about these disparities.
Memorial Sloan Kettering staff, patients, and donors stepped up in extraordinary ways during the COVID-19 pandemic. Meet just some of these heroes.